Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antibiotic Resistance Market
Antibiotic Resistance Market size is valued to be USD 8.2 billion in 2022 and is projected to grow at CAGR of 5.3% and reach USD 13.6 billion by 2032. Some of the major factors driving the growth of this market are increasing incidence of antibiotic resistant infections, growing need for new antibiotic therapies, increasing investment in antibiotic research and development, and increasing global public health concern and awareness.
Antibiotic resistance is an ability of bacteria or other microorganisms to resist the effects of antibiotics that were once effective in treating infections caused by them. This resistance develops when bacteria experience genetic alterations or mutations that enable them to survive and thrive even in the presence of antibiotics, reducing or eliminating the effectiveness of the medications. As a result, infections caused by these resistant bacteria become more difficult to treat, leading to prolonged illness, increased treatment costs, and potentially higher mortality rates.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Antibiotic Resistance Market Size in 2022: | USD 8.2 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.3% |
2032 Value Projection: | USD 13.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 212 |
Tables, Charts & Figures: | 369 |
Segments covered: | Disease, Pathogen, Drug Class, Mechanism of Action, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|